MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
OpGen Total Non Current Liabilities 2011-2025 | OPGN
Annual Total Non Current Liabilities OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 21.2 M | 1.19 M | 1.26 M | 429 K | 545 K | 1.38 M | 4.7 M | 2.23 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.2 M | 429 K | 4.12 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
3.56 M | $ 0.23 | -4.78 % | $ 6.75 M |  USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 39.57 | -1.31 % | $ 1.1 B | USA |
 |
DarioHealth Corp.
DRIO
|
25.8 M | $ 10.32 | 2.79 % | $ 293 M |  Israel |
 |
DexCom
DXCM
|
1.15 B | $ 67.44 | 0.03 % | $ 26 B | USA |
 |
Brainsway Ltd.
BWAY
|
7.58 M | $ 19.37 | 0.41 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 20.47 | -3.49 % | $ 221 M |  China |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
16.4 M | $ 1.52 | -0.33 % | $ 1.93 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
26.9 B | $ 229.62 | -0.66 % | $ 168 B | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | $ 101.58 | 0.03 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 26.68 | -1.22 % | $ 807 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
107 M | $ 6.43 | -1.83 % | $ 583 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.29 M | $ 5.0 | -1.96 % | $ 2.68 M | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 7.08 | -0.84 % | $ 1.54 B | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 18.5 | -0.8 % | $ 454 M | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 19.4 | -1.67 % | $ 1.04 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 101.97 | -0.62 % | $ 4.02 B | USA |
 |
Pacific Biosciences of California
PACB
|
43.9 M | $ 1.79 | -4.79 % | $ 454 M | USA |
 |
Anixa Biosciences
ANIX
|
4.17 M | $ 3.2 | -6.43 % | $ 102 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 26.99 | - | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
13 B | $ 225.88 | -0.03 % | $ 41 B | USA |
 |
Precipio
PRPO
|
1.9 M | $ 23.76 | -0.51 % | $ 30.8 M | USA |
 |
Quidel Corporation
QDEL
|
202 M | $ 28.59 | -1.11 % | $ 1.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.58 B | $ 45.32 | -0.35 % | $ 10.1 B | Niderland |
 |
Guardant Health
GH
|
91.4 M | $ 103.47 | 1.06 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
3.1 B | $ 17.68 | -0.14 % | $ 5 B | USA |
 |
Illumina
ILMN
|
2.04 B | $ 134.81 | -0.38 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 202.73 | -0.57 % | $ 10.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 1.04 | 2.21 % | $ 61.9 M |  Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 175.87 | -0.01 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
62.1 M | $ 6.65 | -2.49 % | $ 862 M | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 253.4 | -0.35 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 181.86 | -0.99 % | $ 15 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
630 M | $ 687.75 | -0.06 % | $ 56.7 B | USA |